Last reviewed · How we verify

Cefuroxime 4,5g

Universitätsklinikum Hamburg-Eppendorf · FDA-approved active Small molecule Quality 2/100

Cefuroxime 4,5g is a Small molecule drug developed by Universitätsklinikum Hamburg-Eppendorf. It is currently FDA-approved.

At a glance

Generic nameCefuroxime 4,5g
SponsorUniversitätsklinikum Hamburg-Eppendorf
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Cefuroxime 4,5g

What is Cefuroxime 4,5g?

Cefuroxime 4,5g is a Small molecule drug developed by Universitätsklinikum Hamburg-Eppendorf.

Who makes Cefuroxime 4,5g?

Cefuroxime 4,5g is developed and marketed by Universitätsklinikum Hamburg-Eppendorf (see full Universitätsklinikum Hamburg-Eppendorf pipeline at /company/universit-tsklinikum-hamburg-eppendorf).

What development phase is Cefuroxime 4,5g in?

Cefuroxime 4,5g is FDA-approved (marketed).

Related